Becton Dickinson (BDX) Tops Q3 EPS by 16c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
BD REPORTS THIRD QUARTER FISCAL 2022 FINANCIAL RESULTS
August 4, 2022 6:30 AM EDTRevenue from continuing operations of $4.6 billion increased 0.7% as reported and 3.8% on currency-neutral basisRevenue from continuing operations driven by base revenue growth of 6.0% as reported, 9.3% currency-neutralWorldwide COVID-only testing revenues of $76 million declined from $300 million in the prior yearGAAP diluted EPS from continuing operations of $1.28; adjusted diluted EPS from continuing operations of $2.66Company raises full year revenue and EPS guidance
FRANKLIN LAKES, N.J., Aug. 4, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its third quarter of fiscal year... More
